Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark McLaughlin

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
F1000Research|May 10, 2019
An in vitro model for studying CNS white matter: functional properties and experimental approachesSilvia Bijland, Gemma Thomson, Matthew Euston, et al.
The Journal of Organic Chemistry|August 5, 2017
Asymmetric Formal Synthesis of the Long-Acting DPP-4 Inhibitor OmarigliptinFeng Peng, Yonggang Chen, Cheng-Yi Chen, et al.
Journal of Fish Diseases|May 29, 2025
Serum Biomarkers in Atlantic Salmon for Differential Diagnosis of Cardiomyopathy Syndrome and Pancreas Disease: Proteomic Identification of Serum Fibrinogen to Enhance Troponin Immunoassay as Optimal Diagnostic ApproachFrancesca Riva, Lauren Elaine Black, Kim D Thompson, et al.
Urologic Oncology|February 11, 2022
Stereotactic ablative radiation therapy for renal cell carcinoma with inferior vena cava tumor thrombusYuval Freifeld, Ivan Pedrosa, Mark Mclaughlin, et al.
Organic Letters|February 7, 2017
Enantioselective Synthesis of 4'-Ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) via Enzymatic DesymmetrizationMark McLaughlin, Jongrock Kong, Kevin M Belyk, et al.
The Lancet. Oncology|November 18, 2022
5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney)Shankar Siva, Muhammad Ali, Rohann J M Correa, et al.
Regulatory Toxicology and Pharmacology : RTP|August 21, 2017
A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategiesChris Barber, Vincent Antonucci, Jens-Christoph Baumann, et al.
Journal of Applied Clinical Medical Physics|April 9, 2026
Reirradiation treatment effects in the clinic (ReTEC) proposal - proof of concept based on spinal cord dose tolerance for reirradiation with stereotactic body radiotherapyJimm Grimm, Anand Mahadevan, Olusola Obayomi-Davies, et al.
Journal of Proteomics|April 10, 2021
Domestic animal proteomics in the 21st century: A global retrospective and viewpoint analysisAndré M Almeida, Syed Azmal Ali, Fabrizio Ceciliani, et al.
ACS Medicinal Chemistry Letters|June 20, 2014
Discovery of MK-4409, a Novel Oxazole FAAH Inhibitor for the Treatment of Inflammatory and Neuropathic PainHarry R Chobanian, Yan Guo, Ping Liu, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
F1000Research|May 10, 2019
An in vitro model for studying CNS white matter: functional properties and experimental approachesSilvia Bijland, Gemma Thomson, Matthew Euston, et al.
The Journal of Organic Chemistry|August 5, 2017
Asymmetric Formal Synthesis of the Long-Acting DPP-4 Inhibitor OmarigliptinFeng Peng, Yonggang Chen, Cheng-Yi Chen, et al.
Journal of Fish Diseases|May 29, 2025
Serum Biomarkers in Atlantic Salmon for Differential Diagnosis of Cardiomyopathy Syndrome and Pancreas Disease: Proteomic Identification of Serum Fibrinogen to Enhance Troponin Immunoassay as Optimal Diagnostic ApproachFrancesca Riva, Lauren Elaine Black, Kim D Thompson, et al.
Urologic Oncology|February 11, 2022
Stereotactic ablative radiation therapy for renal cell carcinoma with inferior vena cava tumor thrombusYuval Freifeld, Ivan Pedrosa, Mark Mclaughlin, et al.
Organic Letters|February 7, 2017
Enantioselective Synthesis of 4'-Ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) via Enzymatic DesymmetrizationMark McLaughlin, Jongrock Kong, Kevin M Belyk, et al.
The Lancet. Oncology|November 18, 2022
5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney)Shankar Siva, Muhammad Ali, Rohann J M Correa, et al.
Regulatory Toxicology and Pharmacology : RTP|August 21, 2017
A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategiesChris Barber, Vincent Antonucci, Jens-Christoph Baumann, et al.
Journal of Applied Clinical Medical Physics|April 9, 2026
Reirradiation treatment effects in the clinic (ReTEC) proposal - proof of concept based on spinal cord dose tolerance for reirradiation with stereotactic body radiotherapyJimm Grimm, Anand Mahadevan, Olusola Obayomi-Davies, et al.
Journal of Proteomics|April 10, 2021
Domestic animal proteomics in the 21st century: A global retrospective and viewpoint analysisAndré M Almeida, Syed Azmal Ali, Fabrizio Ceciliani, et al.
ACS Medicinal Chemistry Letters|June 20, 2014
Discovery of MK-4409, a Novel Oxazole FAAH Inhibitor for the Treatment of Inflammatory and Neuropathic PainHarry R Chobanian, Yan Guo, Ping Liu, et al.
Pageof 9